BGA
CCXI

Belmont Global Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Belmont Global Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-80,000
Closed -$359K – 85
2016
Q2 		$359K Buy
+80,000
New +$300K 0.34% 51

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Belmont Global Advisors's CCXI Position: Q3 2016 in Review

Belmont Global Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q3 2016, closing a stake of 80,000 shares — an estimated $359K sold.

Belmont Global Advisors first reported a position in CCXI in Q4 2013 and held it in 5 quarters. The position peaked at $1.16M in Q1 2014. 72 funds tracked by Wall St. Rank hold CCXI as of Q3 2016.

  • Belmont Global Advisors reported no remaining ChemoCentryx, Inc. position as of Q3 2016 after selling out during the quarter.
  • Belmont Global Advisors sold 80,000 ChemoCentryx, Inc. shares in Q3 2016, an estimated $359K.
  • Belmont Global Advisors first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 5 quarters.
  • Belmont Global Advisors's ChemoCentryx, Inc. position peaked at $1.16M in Q1 2014.
  • 72 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.